Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Medtronic, Inc. (MDT), Merck & Co., Inc. (MRK), AutoZone, Inc. (AZO): Today’s Three Best Stocks

Page 1 of 2

Medtronic, Inc. (NYSE:MDT)There’s hardly any certainty in the market, but even I have to admit it’s become almost comical that the Nasdaq Composite has hit a new high (including intraday highs) in 17 straight sessions while the broad-based S&P 500 (INDEX:GSPC) has now risen 19 consecutive Tuesdays. It’s an odd pattern, but certainly one that’s allowed traders to build upon this year’s incredible gains.

Today, yet again, without a lack of important economic data, leadership from some of the nation’s biggest companies helped drive the S&P 500 higher. Particularly, home-improvement retail chain The Home Depot, Inc. (NYSE:HD) jumped nearly 3% after reporting better-than-expected first-quarter results and raising its full-year outlook. The Home Depot, Inc. (NYSE:HD) finds itself in the sweet spot with commercial construction rebounding and many homeowners still well underwater in their homes and looking to remodel. It’s certainly a company you can trust moving forward.

For the day, the S&P 500 finished higher by 2.87 points (0.17%) to close at 1,669.16, another new record. In spite of the tame move, three S&P 500 components had monstrous moves higher today.

Medical-device maker Medtronic, Inc. (NYSE:MDT) led the pack higher today, tacking on 4.9% after reporting its fourth-quarter results. Skeptics had been concerned with the impact of the medical-device excise tax heading into this report, but Medtronic, Inc. (NYSE:MDT) silenced them with continued steady growth. For the quarter, sales rose by 4% to $4.46 billion as adjusted EPS rose to $1.10. Comparatively, the Street was expecting just $1.03 in EPS on $4.38 billion in revenue. International sales were the big key for Medtronic, Inc. (NYSE:MDT), with its all-important pacemaker and defibrillator line of products seeing sales rise by 3%. Furthermore, emerging-market revenue rose by 14% on a constant currency basis for the quarter. As long as Medtronic, Inc. (NYSE:MDT) continues to exploit strength in burgeoning growth markets, this will remain a solid investment over the long run.

Shares of drugmaker Merck & Co., Inc. (NYSE:MRK) also vaulted higher by 4.7% following a presentation at the UBS Global Healthcare Conference yesterday. Clearly, investors and analysts alike are happy with what they heard from Merck & Co., Inc. (NYSE:MRK) and are encouraged by the pharmaceutical giant’s pipeline. However, as Foolish health-care analyst Max Macaluso points out, Merck & Co., Inc. (NYSE:MRK)’s pipeline isn’t without its uncertainties. As Max notes, the company’s insomnia drug Suvorexant certainly isn’t a lock for approval when it goes before the Food and Drug Administration later this summer.

Page 1 of 2
Loading Comments...